Open Access
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L
Тип публикации: Journal Article
Дата публикации: 2020-12-11
scimago Q1
wos Q1
БС1
SJR: 4.324
CiteScore: 19.6
Impact factor: 12.5
ISSN: 23752548
PubMed ID:
33158912
Multidisciplinary
Краткое описание
X-ray crystal structures of SARS-CoV-2 M pro with dual inhibitors provide a new direction for the designing of COVID-19 antivirals.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
|
|
|
European Journal of Medicinal Chemistry
20 публикаций, 5.78%
|
|
|
Journal of Medicinal Chemistry
14 публикаций, 4.05%
|
|
|
bioRxiv
12 публикаций, 3.47%
|
|
|
Scientific Reports
11 публикаций, 3.18%
|
|
|
International Journal of Molecular Sciences
9 публикаций, 2.6%
|
|
|
Molecules
7 публикаций, 2.02%
|
|
|
Journal of Biomolecular Structure and Dynamics
7 публикаций, 2.02%
|
|
|
RSC Advances
7 публикаций, 2.02%
|
|
|
ACS Central Science
5 публикаций, 1.45%
|
|
|
ACS Pharmacology & Translational Science
5 публикаций, 1.45%
|
|
|
Viruses
4 публикации, 1.16%
|
|
|
Signal Transduction and Targeted Therapy
4 публикации, 1.16%
|
|
|
Computational and Structural Biotechnology Journal
4 публикации, 1.16%
|
|
|
Proteins: Structure, Function and Genetics
4 публикации, 1.16%
|
|
|
Journal of Medical Virology
4 публикации, 1.16%
|
|
|
ACS Infectious Diseases
4 публикации, 1.16%
|
|
|
Journal of Chemical Information and Modeling
4 публикации, 1.16%
|
|
|
Science
3 публикации, 0.87%
|
|
|
Nature Communications
3 публикации, 0.87%
|
|
|
Acta Pharmaceutica Sinica B
3 публикации, 0.87%
|
|
|
Bioorganic Chemistry
3 публикации, 0.87%
|
|
|
Medicinal Research Reviews
3 публикации, 0.87%
|
|
|
Biomolecules
3 публикации, 0.87%
|
|
|
Accounts of Chemical Research
2 публикации, 0.58%
|
|
|
Natural Product Communications
2 публикации, 0.58%
|
|
|
Frontiers in Pharmacology
2 публикации, 0.58%
|
|
|
Frontiers in Drug Discovery
2 публикации, 0.58%
|
|
|
Communications Biology
2 публикации, 0.58%
|
|
|
Medicinal Chemistry Research
2 публикации, 0.58%
|
|
|
5
10
15
20
|
Издатели
|
10
20
30
40
50
60
70
80
|
|
|
Elsevier
73 публикации, 21.1%
|
|
|
American Chemical Society (ACS)
51 публикация, 14.74%
|
|
|
Springer Nature
41 публикация, 11.85%
|
|
|
Cold Spring Harbor Laboratory
37 публикаций, 10.69%
|
|
|
Wiley
36 публикаций, 10.4%
|
|
|
MDPI
29 публикаций, 8.38%
|
|
|
Taylor & Francis
18 публикаций, 5.2%
|
|
|
Royal Society of Chemistry (RSC)
15 публикаций, 4.34%
|
|
|
Frontiers Media S.A.
8 публикаций, 2.31%
|
|
|
American Society for Microbiology
6 публикаций, 1.73%
|
|
|
Bentham Science Publishers Ltd.
5 публикаций, 1.45%
|
|
|
American Association for the Advancement of Science (AAAS)
4 публикации, 1.16%
|
|
|
SAGE
3 публикации, 0.87%
|
|
|
Hindawi Limited
3 публикации, 0.87%
|
|
|
Portland Press
2 публикации, 0.58%
|
|
|
King Saud University
2 публикации, 0.58%
|
|
|
Public Library of Science (PLoS)
2 публикации, 0.58%
|
|
|
Pleiades Publishing
2 публикации, 0.58%
|
|
|
International Union of Crystallography (IUCr)
1 публикация, 0.29%
|
|
|
International Journal of Applied Pharmaceutics
1 публикация, 0.29%
|
|
|
Oxford University Press
1 публикация, 0.29%
|
|
|
Walter de Gruyter
1 публикация, 0.29%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 0.29%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 0.29%
|
|
|
Georg Thieme Verlag KG
1 публикация, 0.29%
|
|
|
10
20
30
40
50
60
70
80
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
346
Всего цитирований:
346
Цитирований c 2025:
33
(9.53%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Sacco M. D. et al. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L // Science advances. 2020. Vol. 6. No. 50.
ГОСТ со всеми авторами (до 50)
Скопировать
Sacco M. D., Ma C., Lagarias P., Gao A., Townsend J. A., Meng X., Dube P., Zhang X., Hu Y., Kitamura N., Hurst B., Tarbet B., Marty M. T., Kolocouris A., Xiang Y., Chen Yu., Wang J. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L // Science advances. 2020. Vol. 6. No. 50.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1126/sciadv.abe0751
UR - https://doi.org/10.1126/sciadv.abe0751
TI - Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L
T2 - Science advances
AU - Sacco, Michael Dominic
AU - Ma, Chunlong
AU - Lagarias, Panagiotis
AU - Gao, Ang
AU - Townsend, Julia Alma
AU - Meng, Xiangzhi
AU - Dube, Peter
AU - Zhang, Xiujun
AU - Hu, Yanmei
AU - Kitamura, Naoya
AU - Hurst, Brett
AU - Tarbet, Bart
AU - Marty, Michael T.
AU - Kolocouris, Antonios
AU - Xiang, Yan
AU - Chen, Yu
AU - Wang, J.
PY - 2020
DA - 2020/12/11
PB - American Association for the Advancement of Science (AAAS)
IS - 50
VL - 6
PMID - 33158912
SN - 2375-2548
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Sacco,
author = {Michael Dominic Sacco and Chunlong Ma and Panagiotis Lagarias and Ang Gao and Julia Alma Townsend and Xiangzhi Meng and Peter Dube and Xiujun Zhang and Yanmei Hu and Naoya Kitamura and Brett Hurst and Bart Tarbet and Michael T. Marty and Antonios Kolocouris and Yan Xiang and Yu Chen and J. Wang},
title = {Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L},
journal = {Science advances},
year = {2020},
volume = {6},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {dec},
url = {https://doi.org/10.1126/sciadv.abe0751},
number = {50},
doi = {10.1126/sciadv.abe0751}
}